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Incubation of pig skin slices with epidermal growth 
factor (EGF) caused an increase in intracellular cyclic 
GMP concentration. A significant increase was found 
after 1 hr of incubation and reached a peak by 6 hr. EGF 
caused no change in the cyclic AMP level nor did it affect 
epinephrine-induced cyclic AMP responses. 
Epidermal growth factor (EGF) was fIrst isolated from ex-
tracts of the male mouse submaxillary gland in 1962 by Cohen 
[1]. In 1975, human EGF was isolated from the urine of pregnant 
women [2]. Preliminary data indicate that the EGF concentra-
tion in human plasma is 2-4 ng/ml [3]. As far as the mechanism 
of action of EGF is concerned, 2 models are currently consid-
ered. One is t hat EGF binds to cell surface receptor(s) and th en 
triggers an intracellular cyclic nucleotide second messenger 
without entering t he cell [4]. Another is that EGF is internalized 
and bound to control site(s) inside the cell and acts without the 
need for cyclic micleotides 15]. In favor of the former concept 
is the fInding of a rise in cyclic AMP and adenylate cyclase 
activity after EGF treatment in corneal epithelium and epider-
mis of mice [6,7]. However others reported that some effects, 
especially the mitogenic effects, of EGF on epithelial cells and 
fIbroblasts may be mediated through lowered levels of cyclic 
AMP [4,8,9]. Reports on the effect ofEGF on cyclic GMP levels 
are essentially limited to a report of a significant increase in 
cyclic GMP by EGF in rabbit lens epithelial cell cultures [6]. 
We have undertaken studies on the effect of EGF on cyclic 
AMP and cyclic GMP systems in pig skin (epidermis). 
MATERIALS AND METHODS 
Cyclic AMP antiseru m, 12r,I-iodinated 2'-O-succinyl cyclic AMP, 
cy?lic GMP antiserum, 12f'I-iodinated 2' -O-succinyl cyclic GMP, a nd 
epidermal growth factor (source = mouse submaxillary gland) were 
obtamed from Colla borative Research Inc. (Waltham, Mass.). Trieth-
ylamme and acetic anhydride were purchased from Eastman Kodak 
(Rochester, N.Y.). E pinephrine hydrochloride was the product of Park 
DaVIS (Bloomfield, N.J .). Hank's balanced salt solution RPMI 1640 
medium, antibiotics and fetal calf serum were purchased 'from GIBCO 
(Grand Island, N.Y.). ALI other chemicals and drugs were of analytical 
reagent grade. 
T he skin slices wen; taken from the back of domestic pigs, weighing 
6~8 k,~, by a. CastrovleJo keratome set at 0.3 mm depth. The "skin 
s lIces contam mamly epiderm is (70-85%) but also include small 
amounts of dermis. D uring this procedure, pigs were anesthetized with 
Nem~utal (dose = .20-30 mg/kg) intraperitoneally. For incubation 
expenments, skm slIces were kept in Hank's balanced salt solu tion at 
4DC. S lices were cut into 5 X 5 mm squares and used within 30 min. 
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After' 15 min preincubation at 37DC, t reatment with EGF was star ted. 
For simultan eous cyclic AMP and cyclic GMP assays, 4 pieces of skin 
were used. For cyclic AMP assay alone one piece of skin was used. For 
short treatments (within 60 min) , incubat ion was carried out with 
Hank's balanced salt solu t ion in a water bath. For longer treatments, 
incubations were performed with RPMI 1640 media, containing 2 mM 
glutamine, 100 units of penicillin per ml, 100 units of streptomycin per 
ml, and 0.25 mcg of fungizone per ml, and were equilibrated with 5% 
CO2 in air in a humidified incubator. After each incubation period, skin 
squares were immediately frozen between 2 Dry Ice plates, and kept in 
a -70DC freezer. 
The cyclic AMP and cycl ic GMP in skin squares were extracted by 
homogenization of the tissue in 2 ml of 1% perchloric acid at 4 DC. 
Trit ium labeled cyclic nucleotides were added during homogenization 
of the t issues for calculating recoveries, which are generally 70% for 
cyclic AMP and 90% for cyclic GMP. Perchloric ac id was then removed 
by precipitation with 6 N KOH, and the pH was adjusted to 7.0, and 
the extracts were applied to Dowex-1 (column = 0.5 x 4.0 cm, chloride 
form 1 X 8, 400 mesh) which had been prewashed with formic ac id. 
The cyclic AMP and cyclic GMP fractions were separated as described 
by Murad , M anganiello, and Vaughan [10], with sligh t modifica tion. 
Cyclic AMP was eluted with 10 ml of 2 N formic acid and cycl ic GMP 
with 12 ml of 5 N formic ac id. When cyclic nucleotides in the media 
were measw'ed, the media were applied to Dowex-1 columns and both 
cyclic nucleotides were eluted as described. The eluates were lyophilized 
in 20 ml serum bottles dissolved in 500 f.ll of H 20, and aliquots were 
assayed. For only cyclic AMP determinations, one skin square was 
homogenized in 1 ml of 5% trichloroacetic acid (TCA) at 4 DC. Aliquots 
of the supernatant were assayed a fter having been lyophilized in the 
presence of 0.1 N H Cl. This procedure removes TCA [11], which 
otherwise in terferes with the radioimmunoassay. Both assays for cyclic 
AMP and cyclic GMP were carried out by the method of radioimmu-
noassay [12] after one step acetylation [13]. Protein was determined by 
the method of Lowry et al [14). 
RESULTS 
The Effects of EGF on the Cyclic GMP Level 
Short treatments with EGF revealed that the intracellular 
cyclic GMP level started to increase at 60 min (Fig 1) . The 
fluctuation during fIrst 20 min is not statistically significant, nor 
is the apparent difference at 40 min. Longer treatments showed 
a peak in the cyclic GMP level at 6 hr. Stimulation was still 
observed after 24 lu' of incubation (Ta ble I) . We also measured 
the cyclic GMP level in the media. The level ranged between 
2.5 to 9.0 frnoles/mg protein of the tissue slices incubated. No 
significant differen ce in the cyclic GMP levels between the 
control and EGF treated groups was found. As far as the 
concentration ofEGF is concerned, 0.05 j.Lg/ rnl had some effect, 
but 0.5 j.Lg/ ml and 5.0 j.Lg/ml had a greater effect on the accu-
mulation of intracellular cyclic GMP (Table II) . 
The Effects of EGF on the Cyclic AMP Level 
Our results indicate there are no significant alterations of 
intracellular cyclic AMP levels after the ad<;lition of EGF for up 
to 24 hr (Table III). Even the largest difference observed at 20 
min (0.65 vs. 0.94 pmol/mg protein) is statistically not signifi-
cant (p = 0.1). 
The Effect of EGF Treatment on the Epinephrine-cyclic 
AMP System 
Although EGF showed no direct effect on cyclic AMP levels, 
it was thought possible that an indirect effect on the respon-
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FIG 1. Time COUl'se of t he changes in intraceUular cyclic GMP 
contents in skin in the absence ("control" ) or the presence (" treated") 
of EGF. The concentration of EGF was 0.5 fLg/ ml. The data summarize 
the results (the mean ± SE fmoles/mg prote in) of 2 separate experi-
ments. n = Number of samples (n = 4 for cont rols and 7 for treated 
except for 0 min control being n = 10) . Each sample was assayed in 
duplicate. The difference in the cyclic GMP level at 60 min of incubation 
is highly significant (p < 0.001) but that at 40 min not highly s ignificant 
(0.05 < p < 0.02) . 
TABLE I. The effect of EGF all. the cyclic GMP content during 24 
hours incubation 
Control Treated 
0 30.2 ± 0.43 
2 hI' 18.2 ± 2.05 26.3 ± 1.65 0.010 < p < 0.025 
6 hr 19.8 ± 1.56 55.6 ± 2.86 p < 0.001 
241u' 12.7 ± 1.24 31.0 ± 6.30 0.010 < p < 0.025 
EGF concentration was 0.5 fLg/ ml. R esults are expressed as fmo l 
cyclic GMP / mg prote in: averages ± SE of 2 independent experiments 
(n = 4, total number of samples analyzed; each sample was assayed in 
duplicate). 
0 
TABLE II. The effect of varying amounts of EGF on intracellular 
cyclic GMP 
Treated 
Control 
0.05 I'g/ Illl 0.5I'g/ llll 5.0I'g/ llll 
13.7 ± 0.88 
(n = 11) 
6 hI' 15.5 ± 0.93 18.9 ± .74 21.8 ± 1.48 26.0 ± 1.02 (n = 11) (n = 5) (n = 8) (n = 5) 
0.025 < p < 0.010 0.005 < p < 0.001 P < 0.001 
Results aJ'e expressed as fmol cycl ic GMP / mg p,·o tein. 
Skin samples were incubated with EG F for 6 hr. An average ± SE is computed 
fTom 2 separate experiments. n = Total number of samples ana lyzed, each in 
duplicate. 
TABLE III. The effect of EGF on intracellular cyclic AMP 
Control Treated 
0 1.26 ± 0.14 
5 min 0.94 ± 0.08 0.98 ± 0.Q7 
10 min 1.05 ± 0.18 1.35 ± 0.25 
20 min 0.65 ± 0.01 0.94 ± 0.16 
40 min 0.73 ± 0.03 0.92 ± 0.18 
60 min 0.96 ± 0.20 1.04 ± 0.28 
S kin samples were treated with 0.5 fLg/ ml of EGF for various periods. 
Each value is an average ± SE of 2 separ ate experiments (n = 6) 
expressed as pmol cyclic AMP / mg protein. Another set of experiments 
with longer incubation periods of 0.5, 1, 2, 4, 6, 8 a nd 24 hI' showed no 
change in the cyclic AMP levels between the control and treated group 
(data not shown). 
siveness of adenyl cyclase might occm. This was tested by "pre-
incubation" of skin slices with EGF and then testing the re-
sponse to a ,B-adrenergic receptor stimulant. (Fig 2). The "pre-
treatment" did not influence th~ responsiveness of the skin 
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FIG 2. Cyclic AMP accumulation in response to epineplu'ine foUow-
ing the EGF treatment. Skin squares were treated with 0.5 fLg/ ml EGF 
up to 8 hr. At various times during the incubation periods, samples 
were transferred into the media with 50 fLM epinephrine for 5 min. 
e---e EGF pretreated; 0---0 con tro l, (no EGF a dded ). Dotted 
lines show base values, i.e. t he cyclic AMP levels without epineplu'ine 
(e ... ·e EGF pre-treated and O · . . ·0 con trol groups). 
cyclic AMP system to epinephrine. We have also pre-treated 
the skin squares with hydrocortisone for 24 hI', and the samples 
were subsequently tested with EGF to see if hydrocortisone 
could alter the EGF effect on cyclic AMP accumulation. No 
significant alterations in the cyclic AMP levels were found 
between EGF-treated groups and con trol groups for incubation 
periods up to 24 hr (data not shown). 
DISCUSSION 
Cyclic nucleotide tissue measurements pose several problems. 
That due to thei.r extremely minu te content appears to be 
overcome, at least in part, by the use of a sensitive radioim-
munoassay. However, one still may note that the baseline cyclic 
GMP content varies considerably from one experiment to an-
other (e.g. those at 0 time in T ables I, II and Fig 1). This 
variability may be largely due to the variation in the dermal 
contamination in the skin slices, since dermis contains much 
smaller amounts of cyclic nucleotides than epidermis. Also , 
once skin is removed from an animal, the level of cyclic GMP 
falls and it is not restored to a ];lormal level dming the 15 min 
pre-incubation period. The extent of this fall may vary for each 
experiment. However, within each experiment where control 
and experimental skin squares are from the same skin, the 
results are reproducible. 
It is always difficult to determine a proper dosage for a 
chemical agent in an in vitro system and this is also true for 
EGF. The in vivo level is about 5 ng/ ml and this concentration 
(5~20 ng/ml) has effects in the in vitro systems of Rheinwald 
and Green [15], Baker et al [16] and Shechter, Hernaez, and 
Cuatrecasas [17]. However, these systems dealt with pme ker-
atinocyte or fibroblast cell cultmes. Hassell and Pratt [9] used 
an EGF concentration of 2000 ng/ ml for their organ cultme 
system of unfused palatal shelves and quoted that the level was 
comparable to that used by Cohen [18] and Hassel [19] in 
previous organ culture studies. Om floating skin slice is an 
organ cultme system and the use of EGF concentrations of 
from 50 ng/ ml to 500 ng/ ml does not seem excessive. 
Hollenberg and Cuatrecasas [4] proposed that EGF could 
alter the level of intracellular cyclic AMP in human fibroblasts 
and modulate the ability of the cells to initiate polynucleotide 
synthesis. They stated that the EGF-induced synthesis of RNA 
and DNA in human fibroblasts was inhibited by theophylline 
and/ or dibutyryl cyclic AMP as well as by cholera toxin, whose 
actions were believed to be mediated through cyclic AMP. 
R ecently, Frati et al [7] presented evidence that EGF decreased 
both adenylate cyclase activity and cyclic AMP in mouse epi-
dermis by about 30%, but only after 3-5 days of treatment with 
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EGF. Our results show that the adenylate cyclase system of pig 
skin is not affected by EGF. 
In mouse fibroblasts in culture [20,21], in lymphocytes [22], 
and in catecholamine-stimulated rodent salivary glands [23], an 
increase in cell proliferation is preceded by an immediate in-
crease in cyclic GMP. With respect to epidermal systems, there 
are only 2 reports on cyclic GMP available: i.e., hyperprolifer-
ative psoriatic epidermis had a higher cyclic GMP level than 
uninvolved and normal epidermis [24] and mouse epidermis 
after multiple treatments with the tumor promotor phorbol 
myristate acetate showed increases in cyclic GMP [25]. In our 
in vitro floating system, intracellular cyclic GMP started to 
increase at one hour after the addition of EGF and reached its 
maximum at 6 hr. There was no evidence of an immediate 
response to EGF. This is contrary to the finding of rapid cyclic 
GMP increases in the rabbit lens epithelial system [6]. 
EGF and tetradecanoyl-phorbol-acetate (TPA) share several 
biological effects, such as the induction of plasminogen activator 
[26], growth stimulation, enhancement of sugar transport, in-
duction of ornithine decarboxylase and prostaglandin synthesis. 
TP A and other phorbol esters have an ability to diminish the 
f3-adrenergic responsiveness of epidermal cells, though they are 
not involved in any change of the basal cyclic AMP level [27]. 
The accumulation of cyclic AMP in response to isoproterenol 
or the naturally occulTing catecholamine, epinephrine, was 
significantly diminished 9 to 24 hr after topical application of 
TP A. These reports prompted us to search for the same effect 
of EGF on epidermal cells. Although the previous results ruled 
out any direct effect of EGF on adenylate cyclase, it was still 
possible that EGF might alter the responsiveness of adenylate 
cyclase to stimulation. Thus we tested the effects of "pre-
incubation" with EGF on the cyclic AMP accumulation in 
response to epinephrine (Fig 2). For up to 8 hr no significant 
differences between controls and EGF-treated skin were de-
tected. 
Baker et al [16] reported that dexamethasone enhanced the 
mitogenic response of human foreskin cells to EGF. Paralleling 
their increased responsiveness to EGF growth stimulation, dex-
amethasone treated cells exhibited a 50-100% increased ability 
to bind 125I_EGF during the prolonged exposure to EGF that 
was required to stimulate cell division. In our system, however, 
the pre-treatment of skin with hydrocortisone for 24 how's did 
not change its sensitivity to EGF as tested by cyclic AMP 
accumulation. 
Two different explanations for enhancement of biological 
effect by EGF are available. Recently, Shechter et al [17] 
reported that the enhancement of DNA synthesis by EGF in 
cultured human fibroblasts was demonstrable 24 h:r after incu-
bation of cells at 37°C with very low concentrations of the 
hormone for short periods (30 min) followed by washing of the 
cells to remove the free hormone in the medium. Also 'the 
~~d.ition of specific, pw'ified anti-EGF IgG as late as 8 hr after 
LnltIal hormone exposure completely reversed the biological 
effects of the hormone. Thus EGF may not have to enter the 
cell to exert its biological effect. Although several authors [5-9] 
have reported that EGF acts through the cyclic AMP system 
in diff~rent tissue sy.stems, we could not demonstrate any 
alteratLOns of the cychc AMP level in skin following the treat-
ment by EGF. Therefore cyclic AMP is not an intracellular 
second messenger for the biological effect of EGF. 
Is EGF stimulation of epidermal cell proliferation mediated 
tlu'ough cyclic G~P? Carpenter, King, and Cohen [28] studied 
the phosphorylatLOn ?y EGF in a cell-free membrane prepara-
tion from a human epIdermoid carcinoma cell line, and reported 
that maximal stimulation of the membrane phosphorylation 
occuned in the presence of 3 x 10- 8 M EGF, but the presence 
of cyclic AMP or cyclic GMP (10- 4_10- 6 M) had no discernable 
effect on the phosphorylation reaction. These results plus ow' 
finding that stimulation of cyclic GMP formation in pig skin by 
EGF does not occur quickly but requires hours leads to the 
Vol. 74, No.4 
conclusion that this effect on cyclic GMP is a consequence of 
the action of EGF and probably not related to its action. 
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Announcement 
A meeting on anthralin will be held at Sophia Antipolis near Nice, France on Oct 17 and 18, 1980. The 
meeting will focus on current concepts in the treatment of psoriasis with anthralin. Organizers of the 
meeting are Prof. Malcolm Greaves (London), Prof. Lennart Juhlin (Uppsala) , Prof. Hans Schaeffer 
(Sophia Antipolis). 
The main topic, including some clinical experiences, will be covered by guest speakers. Free commu-
nications on the theoretical aspects of the topic are invited. For information contact Prof. Hans Schaefer, 
eIRE, Sofia Antipolis 06560, Zalbonne, France, Telephone 93-74-12-00. 
